Role of circulating tumour marker CA 19.9 and antiangiogenic therapy with bevacizumab in patients with metastatic colorectal cancer on first line systemic treatment

Autor: Formica V, Portarena I, Fiaschetti V, Del Vecchio G., Massara M., Sica G., Sileri P, Grenga I, Pallone F., Roselli M.
Přispěvatelé: Formica, V, Portarena, I, Fiaschetti, V, Del Vecchio, G., Massara, M., Sica, G., Sileri, P, Grenga, I, Pallone, F., Roselli, M.
Rok vydání: 2008
Databáze: OpenAIRE